, and 1,722.70 million baht for year 2016, 2017, and 2018 respectively. As can be seen, the revenue from sale increased continuously every year. In the year 2018, increased orders and the market expansion
found in various jurisdictions raised serious concerns among capital market regulators on the quality of financial statements and more stringent quality control on audit work has been imposed to regain
/LawandRegulations/ShareWarrant.aspx English (United States) IndependentAuditOversight found in various jurisdictions raised serious concerns among capital market regulators on the quality of financial statements and
jurisdictions raised serious concerns among capital market regulators on the quality of financial statements and more stringent quality control on audit work has been imposed to regain https://www.sec.or.th/EN
compared to Q2/2019 as following results: Revenue Q2/2020, the Company and its subsidiaries had total revenue of 255.5 MB, increased from Q2/2019 in the amount of 26.2 MB or 11.43 percent (Domestic sales
the total revenue increased from Q1–2021, representing an increase of 257.0 MB or 14.1% and significantly increased compare to Q2–2020, representing an increase of 893.6 MB or 75.2%. This is because the
Polymer business unit was risen by 5.55%. And the sales value of Specialty Chemicals business unit was increased by 26.17%. The 3.27% decrease in total sales revenue was mainly due to the decline in sales
admin expenses of 26.0 MB, increased from Q1/2019 in the amount 5.6 MB, or 27.9 percent (20.3 MB in Q1/2019) as result from new production unit at Bangpoo and the impact from the Thai Financial Reporting
drop in selling price led by oil price fluctuation. This also caused a severe price war among the traders of plastic resins and petrochemical industry. Total selling and administrative expenses increased
from both domestic and international demand which were impacted by the coronavirus (COVID-19) pandemic and various severe measures for controlling the outbreak. Therefore it affected to the economic